An observational study in Renal Infarction, sponsored by Sheba Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2018-05-01.
Sponsored by Sheba Medical Center · Observational
Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement
Each patient will undergo Magnetic Resonance assessment of the kidneys before the TAVR. on the third to 7th day after the ATVR, a second MRI to the kidneys will be performed. we will assess the changes and new lesions between both MRI tests and will perform a qualitative and quantitative measurement.
71 studies on the registry are indexed under Infarction; 15 are open to participants now.
This study's planned enrollment of 20 is below the median of 119 across 23 observational studies indexed under Infarction.
Browse Infarction studies →Sheba Medical Center is the lead sponsor of 678 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients that will be undergoing trans-cather aortic valve replacement for severe symptomatic aortic stenosis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Magnetic Resonance test for kidney
New Renal Infarction
New low signal intensity lesions on diffusion weighted images on MRI.
Time frame: one year
Hematuria
New hematuria on urine test.
Time frame: one year
Elevation in Blood Pressure
Delta of more than 5%
Time frame: one year
Elevation in Plasma Renin Activity
Delta of more than 5%
Time frame: one year
Elevation in Aldosteron level
Delta of more than 5%
Time frame: one year
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.